Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Clariane (KRNMF) Stock Price & Analysis

KRNMF Stock Chart & Stats

$4.34$0.00(0.00%)
At close: 4:00 PM EDT
$4.4$4.5$4.6$4.713 Apr28 Apr1 Jul
Day’s Range
$4.18 - $4.49
52-Week Range
$3.96 - $5.27
Previous Close
$4.34
Volume
N/A
Average Volume (3M)
0
Market Cap
$1.28B
Enterprise Value
$8.69B
Total Cash (Recent Filing)
$1.42B
Total Debt (Recent Filing)
$8.35B
Price to Earnings (P/E)
79.9
Beta
0.07
Next Earnings
Feb 25, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Operating Resilience

Strong revenue growth alongside relatively stable operating margins indicates resilient demand across Clariane’s care activities. This combination supports continued operating cash generation and suggests the core business can absorb growth investments while maintaining its earning capacity over the coming quarters.

Consistent Positive Cash Generation

Consistently positive operating cash flow and free cash flow provide an important foundation for funding care operations, investment, and financial obligations internally. Improving free cash flow strengthens flexibility, although its durability still depends on maintaining operating performance and controlling funding demands.

Diversified Care-services Platform

Coverage of residential, post-acute, mental-health, psychiatric, and home-care services gives Clariane multiple care pathways and revenue sources. Its presence across several European markets can support continuity of demand and reduce reliance on one patient group, service line, or country.

Bears Say

Worsening Leverage

The sharp increase in debt-to-equity makes the balance sheet more sensitive to financing costs, earnings volatility, and any pressure on operating cash flow. Elevated leverage can restrict capital allocation and leave less financial flexibility to invest in facilities or manage weaker trading periods.

Weak Bottom-line Profitability

Near-breakeven net income shows that stable operating margins are not translating into meaningful shareholder earnings. Persistent pressure below operating profit reduces retained capital, limits resilience against adverse changes, and makes future results more exposed to financing and non-operating costs.

Moderate Debt Paydown Capacity

Although cash generation is positive, annual cash flow covers only a moderate share of total debt, so deleveraging may take time without sustained improvement. The gap between strong free cash flow and near-zero earnings also warrants monitoring of how durable that cash conversion remains.

Clariane News

KRNMF FAQ

What was Clariane’s price range in the past 12 months?
Clariane lowest stock price was $3.96 and its highest was $5.27 in the past 12 months.
What is Clariane’s market cap?
Clariane’s market cap is $1.28B.
When is Clariane’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Clariane’s earnings last quarter?
Clariane released its earnings results on Jul 29, 2026. The company reported -$0.149 earnings per share for the quarter.
Is Clariane overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Clariane pay dividends?
Clariane does not currently pay dividends.
What is Clariane’s EPS estimate?
Clariane’s EPS estimate for its next earnings report is not yet available.
What happened to Clariane’s price movement after its last earnings report?
Clariane reported an EPS of -$0.149 in its last earnings report. Following the earnings report the stock price went up 2.544%.
Which hedge fund is a major shareholder of Clariane?
Currently, no hedge funds are holding shares in KRNMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology